Search research articles
Contact Us
Filters
Showing results (131-140 of 180) with videos related to
Page
of 18
Sort By:
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
April 1, 1997
Characterization of the fate of midline epithelial cells during the fusion of mandibular prominences in vivo
Y Chai, Y Sasano, P Bringas, et al.
Development (Cambridge, England)
|
October 31, 2001
Abnormal function of astroglia lacking Abr and Bcr RacGAPs
V Kaartinen, I Gonzalez-Gomez, J W Voncken, et al.
Nature
|
November 17, 1983
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia
N Heisterkamp, J R Stephenson, J Groffen, et al.
Leukemia
|
February 1, 1987
Deletion of c-fms sequences in the 5q- syndrome
C R Bartram, J V Böhlke, S Adolph, et al.
The New England Journal of Medicine
|
December 5, 1985
Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome
K Stam, N Heisterkamp, G Grosveld, et al.
Toxicology and Applied Pharmacology
|
May 1, 1992
Transfection with gamma-glutamyl transpeptidase enhances recovery from glutathione depletion using extracellular glutathione
E Rajpert-De Meyts, M Shi, M Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 20, 1998
Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI)
W T Kyono, R de Jong, R K Park, et al.
European Journal of Biochemistry
|
November 1, 1996
Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells
A J Groffen, C A Buskens, K Tryggvason, et al.
International Journal of Molecular Medicine
|
March 20, 2001
The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice
N Heisterkamp, J W Voncken, D Senadheera, et al.
Leukemia
|
November 4, 2006
Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2
S Mishra, V Pertz, B Zhang, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 180) with videos related to
Sort By:
Page
of 18
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
April 1, 1997
Characterization of the fate of midline epithelial cells during the fusion of mandibular prominences in vivo
Y Chai, Y Sasano, P Bringas, et al.
Development (Cambridge, England)
|
October 31, 2001
Abnormal function of astroglia lacking Abr and Bcr RacGAPs
V Kaartinen, I Gonzalez-Gomez, J W Voncken, et al.
Nature
|
November 17, 1983
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia
N Heisterkamp, J R Stephenson, J Groffen, et al.
Leukemia
|
February 1, 1987
Deletion of c-fms sequences in the 5q- syndrome
C R Bartram, J V Böhlke, S Adolph, et al.
The New England Journal of Medicine
|
December 5, 1985
Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome
K Stam, N Heisterkamp, G Grosveld, et al.
Toxicology and Applied Pharmacology
|
May 1, 1992
Transfection with gamma-glutamyl transpeptidase enhances recovery from glutathione depletion using extracellular glutathione
E Rajpert-De Meyts, M Shi, M Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 20, 1998
Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI)
W T Kyono, R de Jong, R K Park, et al.
European Journal of Biochemistry
|
November 1, 1996
Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells
A J Groffen, C A Buskens, K Tryggvason, et al.
International Journal of Molecular Medicine
|
March 20, 2001
The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice
N Heisterkamp, J W Voncken, D Senadheera, et al.
Leukemia
|
November 4, 2006
Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2
S Mishra, V Pertz, B Zhang, et al.
Page
of 18